-
Newer antipsychotics and upcoming molecules for schizophrenia.
European journal of clinical pharmacology 20130801
-
Population pharmacokinetics of blonanserin in Chinese healthy volunteers and the effect of the food intake.
Human psychopharmacology 20130301
-
Blonanserin, a novel atypical antipsychotic agent not actively transported as substrate by P-glycoprotein.
Progress in neuro-psychopharmacology & biological psychiatry 20121001
-
Quetiapine-induced insulin resistance after switching from blonanserin despite a loss in both bodyweight and waist circumference.
Psychiatry and clinical neurosciences 20121001
-
Development and validation of a stability-indicating gas chromatographic method for quality control of residual solvents in blonanserin: a novel atypical antipsychotic agent.
Journal of chromatographic science 20120901
-
Simultaneous determination of blonanserin and its metabolite in human plasma and urine by liquid chromatography-tandem mass spectrometry: application to a pharmacokinetic study.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20120815
-
Improvement in quetiapine-induced hypoglycemia following a switch to blonanserin.
Psychiatry and clinical neurosciences 20120601
-
The relationship between the plasma concentration of blonanserin, and its plasma anti-serotonin 5-HT(2A) activity/anti-dopamine D₂ activity ratio and drug-induced extrapyramidal symptoms.
Psychiatry and clinical neurosciences 20120301
-
Effect of blonanserin on cognitive function in antipsychotic-naïve first-episode schizophrenia.
Human psychopharmacology 20120101
-
Association of typical versus atypical antipsychotics with symptoms and quality of life in schizophrenia.
PloS one 20120101
-
Role of aripiprazole in treatment-resistant schizophrenia.
Neuropsychiatric disease and treatment 20120101
-
Functional potencies of dopamine agonists and antagonists at human dopamine D₂ and D₃ receptors.
European journal of pharmacology 20110901
-
Blonanserin in the treatment of delirium.
Psychiatry and clinical neurosciences 20110601
-
Three cases of schizophrenia showing improvement after switching to blonanserin.
Psychiatry and clinical neurosciences 20110601
-
Olfactory reference syndrome treated by blonanserin augmentation.
Psychiatry and clinical neurosciences 20110301
-
Effect of novel atypical antipsychotic, blonanserin, on extracellular neurotransmitter level in rat prefrontal cortex.
European journal of pharmacology 20110225
-
Neuroleptic malignant syndrome induced by blonanserin.
The Journal of neuropsychiatry and clinical neurosciences 20110101
-
Comparative study of treatment continuation using second-generation antipsychotics in patients with schizophrenia or schizoaffective disorder.
Neuropsychiatric disease and treatment 20110101
-
Systematic drug repositioning based on clinical side-effects.
PloS one 20110101
-
A case control association study and cognitive function analysis of neuropilin and tolloid-like 1 gene and schizophrenia in the Japanese population.
PloS one 20110101
-
Five Alzheimer's disease cases with refractory behavioural psychological symptoms of dementia treated with blonanserin.
Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society 20101201
-
Adjunctive treatment with low-dosage aripiprazole for blonanserin-induced hyperprolactinemia in a female patient with schizophrenia.
Progress in neuro-psychopharmacology & biological psychiatry 20101001
-
Case of delirium complicated with pneumonia that improved with blonanserin administration.
Psychiatry and clinical neurosciences 20101001
-
Effect of dose timing in relation to food intake on systemic exposure to blonanserin.
European journal of clinical pharmacology 20100901
-
Atypical antipsychotic properties of blonanserin, a novel dopamine D2 and 5-HT2A antagonist.
Pharmacology, biochemistry, and behavior 20100801
-
Efficacy and tolerability of Blonanserin in the patients with schizophrenia: a randomized, double-blind, risperidone-compared trial.
Clinical neuropharmacology 20100701
-
Blonanserin: a review of its use in the management of schizophrenia.
CNS drugs 20100101
-
Fluvoxamine for blonanserin-associated akathisia in patients with schizophrenia: report of five cases.
Annals of general psychiatry 20100101
-
Beneficial effects of loxapine on agitation and breathing patterns during weaning from mechanical ventilation.
Critical care (London, England) 20100101
-
The relationship between the daily dose, the plasma concentration of blonanserin, and its plasma anti-dopamine D2 and anti-serotonin 5-HT2A activity.
Human psychopharmacology 20100101
-
Sensitive analysis of blonanserin, a novel antipsychotic agent, in human plasma by ultra-performance liquid chromatography-tandem mass spectrometry.
Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20100101
-
Efficacy of blonanserin in combination therapy for treatment-resistant depression.
Psychiatry and clinical neurosciences 20090801
-
The efficacy and safety of blonanserin compared with haloperidol in acute-phase schizophrenia: a randomized, double-blind, placebo-controlled, multicentre study.
CNS drugs 20090101
-
[Pharmacological profiles and clinical effects of blonanserin (Lonasen) on schizophrenia].
Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20081201
-
Syntheses and properties of the major hydroxy metabolites in humans of blonanserin AD-5423, a novel antipsychotic agent.
Bioorganic & medicinal chemistry letters 20050215
-
Atypical properties of several classes of antipsychotic drugs on the basis of differential induction of Fos-like immunoreactivity in the rat brain.
Life sciences 20041126
-
Effect of AD-5423 on animal models of schizophrenia: phencyclidine-induced behavioral changes in mice.
Neuroreport 20030210
-
Crystal structure of an antipsychotic agent, 2-(4-ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine (blonanserin).
Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20021101
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20021101
-
The effects of neuroleptics on the GABA-induced Cl- current in rat dorsal root ganglion neurons: differences between some neuroleptics.
British journal of pharmacology 20020301
-
Blonanserin. AD 5423.
Drugs in R&D 20020101
-
Pharmacological profile of AD-5423, a novel antipsychotic with both potent dopamine-D2 and serotonin-S2 antagonist properties.
The Journal of pharmacology and experimental therapeutics 19930101
